Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb;51(3):883-884.
doi: 10.1007/s00259-023-06506-8.

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

Davide Bianco  1 , Carmela Nappi  2 , Michele Klain  1
Affiliations
Editorial

Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule

Davide Bianco et al. Eur J Nucl Med Mol Imaging. 2024 Feb.
No abstract available

PubMed Disclaimer

References

    1. Volpe F, Nappi C, Piscopo L, Zampella E, Mainolfi CG, Ponsiglione A, et al. Emerging role of nuclear medicine in prostate cancer: current state and future perspectives. Cancers. 2023;15:4746. - PubMed - PMC
    1. Galletti G, Leach BI, Lam L, Tagawa ST. Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer. Cancer Treat Rev. 2017;57:16–27. - PubMed
    1. Klain M, Gaudieri V, Petretta M, Zampella E, Storto G, Nappi C, et al. Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer. Future Sci OA. 2021;7(8):FSO719. - PubMed - PMC
    1. Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DC. Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. Cancer. 2006;106:2452–8. - PubMed
    1. Kuppen MC, Westgeest HM, Van Der Doelen MJ, Van Den Eertwegh AJ, Coenen JL, Aben KK, et al. Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer. Future Oncol. 2020;16:1371–84. - PubMed

Publication types

MeSH terms

LinkOut - more resources